|
The US Food and Drug Administration (FDA) approved Risedronate for
treatment and prevention of Paget’s disease in 1998 and the
prevention and treatment of osteoporosis in 1999. FDA has given its
approval to a brand new four month dose of 150mg of Actonel for
treatment prevention of post menopausal osteoporosis. Risedronate is
approved as a drug for women who have entered the menopausal phase
of their life.
The drug has shown positive results for bringing down the number of
fractures in women who are facing both menopause and osteoporosis.
The effectiveness of the once a month dose and the regular daily
dose was checked and the results were found to be similar. The BMD
or bone mineral density had the same amount of hike in patients
taking the daily dose and those taking the once a month dose.
More than 55 million prescriptions of for this drug have been given
to the patients in the United States of America itself. The
manufacturer of this pill is confident that it is the future
solution to all bone related problems. They are so confident as the
results of the clinical trials are very encouraging. The ever
increasing sale of Actonel is another reason why the manufacturer is
so confident.
Osteoporosis is such a big problem especially for those in the old
age. The solution to this problem is to go for a knee replacement
surgery but that will be too expensive and the only solution
available then is to consult a doctor and start your course of
Actonel. This drug has slowed down the bone depletion process and
increases the production of calcium in your bones, which makes life
easier for you. Women who are in their late forties and early
fifties start to develop this problem but now you need not worry.
All you have to do is take Actonel and wait for age to catch up with
you.
|
